Rheumatology (Oxford, England)
Clinical Efficacy of JAK Inhibitors for Rheumatoid Arthritis Patients with Poor-Prognosis Factors: The ANSWER Cohort Study.
Yuji Nozaki, Koichi Murata, Akira Onishi, Kohei Tsujimoto, Wataru Yamamoto, Hirotaka Yamada, Sho Sendo, Motomu Hashimoto, Tadashi Okano, Hideyuki Shiba, Yuri Hiramatsu, Yonsu Son, Naofumi Yoshida, Rika Fukuda, Yumi Morimoto
Published: 202510.1093/rheumatology/keaf552
Abstract
OBJECTIVES: We evaluated the efficacy of Janus kinase inhibitors (JAKi) compared with tumor necrosis factor inhibitors (TNFi) in rheumatoid arthritis (RA) patients with poor-prognosis factors (PPFs), including ACPA or RF positivity, Clinical Disease…
Preview only. Read the full abstract at the source